Sub-Total: $0.00
Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Complimentary
Related products
-
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more -
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more -
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more -
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
